NCT04946188View on ClinicalTrials.gov

Translating Biometric Data Into Blood Glucose Levels

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 21, 2020

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Diabetes Type 2
Interventions
DEVICE

Opuz NICGM

A wearable and non-invasive prototype device that allows for measurement of bioimpedance data with the aim to help develop a mathematical model to predict blood glucose levels.

Trial Locations (1)

2044

Scimita Operations, Sydney

All Listed Sponsors
lead

Scimita Operations Pty Ltd.

INDUSTRY

NCT04946188 - Translating Biometric Data Into Blood Glucose Levels | Biotech Hunter | Biotech Hunter